| JOURNAL OF MOLECULAR BIOLOGY | 卷:327 |
| Crystal structure of human β-hexosaminidase B:: Understanding the molecular basis of Sandhoff and Tay-Sachs disease | |
| Article | |
| Mark, BL ; Mahuran, DJ ; Cherney, MM ; Zhao, DL ; Knapp, S ; James, MNG | |
| 关键词: hexosaminidase; Sandhoff; Tay-Sachs; anchimeric assistance; X-ray crystal structure; | |
| DOI : 10.1016/S0022-2836(03)00216-X | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
In humans, two major beta-hexosaminidase isoenzymes exist: Hex A and Hex B. Hex A is a heterodimer of subunits alpha and beta (60% identity), whereas Hex B is a homodimer of beta-subunits. Interest in human beta-hexosaminidase stems from its association with Tay-Sachs and Sandhoff disease; these are prototypical lysosomal storage disorders resulting from the abnormal accumulation of G(M2)-ganglioside (G(M2)). Hex A degrades G(M2) by removing a terminal N-acetyl-D-galactosamine (beta-GalNAc) residue, and this activity requires the G(M2)-activator, a protein which solubilizes the ganglioside I for presentation to Hex A. We present here the crystal structure of human Hex B, alone (2.4 Angstrom) and in complex with the mechanistic inhibitors GalNAc-isofagomine (2.2 Angstrom) or NAG-thiazoline (2.5 Angstrom). From these, and the known X-ray structure of the G(M2)-activator, we have modeled Hex A in complex with the activator and ganglioside. Together, our crystallographic and modeling data demonstrate how a and beta-subunits dimerize to form either Hex A or Hex B, how these isoenzymes hydrolyze diverse substrates, and how many documented point mutations cause Sandhoff disease (beta-subunit mutations) and Tay-Sachs disease (alpha-subunit mutations). (C) 2003 Elsevier Science Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_S0022-2836(03)00216-X.pdf | 2281KB |
PDF